A citation-based method for searching scientific literature

Philip J Mease, Iain B McInnes, Bruce Kirkham, Arthur Kavanaugh, Proton Rahman, Désirée van der Heijde, Robert Landewé, Peter Nash, Luminita Pricop, Jiacheng Yuan, Hanno B Richards, Shephard Mpofu. N Engl J Med 2015
Times Cited: 482



Iain B McInnes, Philip J Mease, Christopher T Ritchlin, Proton Rahman, Alice B Gottlieb, Bruce Kirkham, Radhika Kajekar, Eumorphia-Maria Delicha, Luminita Pricop, Shephard Mpofu. Rheumatology (Oxford) 2017
Times Cited: 86




List of shared articles



Times cited

Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries.
Brigitte Michelsen, Stylianos Georgiadis, Daniela Di Giuseppe, Anne G Loft, Michael J Nissen, Florenzo Iannone, Manuel Pombo-Suarez, Herman Mann, Ziga Rotar, Kari K Eklund,[...]. Arthritis Care Res (Hoboken) 2022
6

Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: Physical and pharmacological properties underlie the observed clinical efficacy and safety.
Frank Kolbinger, Franco Di Padova, Atul Deodhar, Jason E Hawkes, Christine Huppertz, Torsten Kuiper, Iain B McInnes, Christopher T Ritchlin, David Rosmarin, Georg Schett,[...]. Pharmacol Ther 2022
4

Gastroenterological safety of IL-17 inhibitors: a systematic literature review.
Bénédicte Caron, Jean-Yves Jouzeau, Pierre Miossec, Nadine Petitpain, Pierre Gillet, Patrick Netter, Laurent Peyrin-Biroulet. Expert Opin Drug Saf 2022
2

A review of secukinumab in psoriasis treatment.
Scott H Berg, Esther A Balogh, Rima I Ghamrawi, Steven R Feldman. Immunotherapy 2021
4

Safety of secukinumab for the treatment of active ankylosing spondylitis.
Javier Loricera, Eva Galíndez-Aguirregoikoa, Ricardo Blanco. Expert Opin Drug Saf 2021
3

A Systematic Review With Network Meta-Analysis of the Available Biologic Therapies for Psoriatic Disease Domains.
Tiago Torres, Anabela Barcelos, Paulo Filipe, João Eurico Fonseca. Front Med (Lausanne) 2021
5

Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study.
Roberta Ramonda, Mariagrazia Lorenzin, Antonio Carriero, Maria Sole Chimenti, Raffaele Scarpa, Antonio Marchesoni, Ennio Lubrano di Scorpaniello, Carlo Salvarani, Alberto Cauli, Angelo Semeraro,[...]. RMD Open 2021
12

Joint Statement (DZK, DGRh, DDG) on the Tuberculosis Risk with Treatment Using Novel Non-TNF-Alpha Biologicals.
R Diel, T Schaberg, A Nienhaus, R Otto-Knapp, C Kneitz, A Krause, M Fabri, U Mrowietz, T Bauer, B Häcker. Pneumologie 2021
0


Secukinumab Efficacy on Enthesitis in Patients With Ankylosing Spondylitis: Pooled Analysis of Four Pivotal Phase III Studies.
Georg Schett, Xenofon Baraliakos, Filip Van den Bosch, Atul Deodhar, Mikkel Østergaard, Ayan Das Gupta, Shephard Mpofu, Todd Fox, Adam Winseck, Brian Porter,[...]. J Rheumatol 2021
3

Management of particular clinical situations in psoriatic arthritis: an expert's recommendation document based on systematic literature review and extended Delphi process.
Rosario García-Vicuña, Noemí Garrido, Susana Gómez, Beatriz Joven, Rubén Queiro, Julio Ramírez, Francisco Rebollo, Estíbaliz Loza, Agustí Sellas. Rheumatol Int 2021
1

Real world effectiveness and satisfaction with secukinumab in the treatment of patients with psoriatic arthritis: a population survey in five European countries.
Philip G Conaghan, Dorothy L Keininger, Elizabeth A Holdsworth, Nicola Booth, Niraj N Modi, Haijun Tian, Uta Kiltz. Curr Med Res Opin 2021
0

Secukinumab provides sustained improvement in signs and symptoms and low radiographic progression in patients with psoriatic arthritis: 2-year (end-of-study) results from the FUTURE 5 study.
Philip J Mease, Robert Landewé, Proton Rahman, Hasan Tahir, Atul Singhal, Elke Boettcher, Sandra Navarra, Aimee Readie, Shephard Mpofu, Eumorphia Maria Delicha,[...]. RMD Open 2021
3